ABC News Australia
By Madeline Genner for PM
N0vember 24, 2009
A US woman has been awarded more than $80 million in punitive damages and more than $4 million in compensation after she developed breast cancer.
She argued successfully that her breast cancer was linked to a hormone replacement drug.
In a second case, another woman was awarded more than $30 million.
The jurors heard testimony that Wyeth Pharmaceuticals, which is now owned by Pfizer, paid consultants and ghostwriters of medical journals to play down concerns of breast cancer.
Across the US more than 10,000 product liability cases have been filed over hormone replacement drugs, and this week’s verdicts could lead to similar cases in Australia.